Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value
Merck & Co. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value increased by 9.2% to $272.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $249.00M to $272.00M. Over 4 years (FY 2021 to FY 2025), Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value shows an upward trend with a 6.4% CAGR.
Analysis
How to read this metric
Higher values indicate a larger commitment to equity-based compensation, often used to align long-term employee interests with shareholder value.
Detailed definition
This metric captures the aggregate intrinsic value of share-based options that are both vested and expected to vest. It...
Peer comparison
Commonly reported by large-cap firms with robust equity incentive programs.
other_share_based_compensation_arrangement_by_share_base_33cb6aHistorical Data
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $212.00M | $539.00M | $438.00M | $249.00M | $272.00M |
| QoQ Change | — | +154.2% | -18.7% | -43.2% | +9.2% |
| YoY Change | — | +154.2% | -18.7% | -43.2% | +9.2% |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value at Other Companies
Frequently Asked Questions
- What is Merck & Co.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value?
- Merck & Co. (MRK) reported share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value of $272.00M in Q4 2025.
- How has Merck & Co.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value changed year-over-year?
- Merck & Co.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value increased by 9.2% year-over-year, from $249.00M to $272.00M.
- What is the long-term trend for Merck & Co.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value?
- Over 4 years (2021 to 2025), Merck & Co.'s share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value has grown at a 6.4% compound annual growth rate (CAGR), from $212.00M to $272.00M.
- What does share-based compensation arrangement by share-based payment award, options, vested and expected to vest, outstanding, aggregate intrinsic value mean?
- The total value of all vested and expected-to-vest employee stock options based on current market prices.